| Literature DB >> 26443266 |
Tobias Schwerd1, Andrea V Khaled2, Manfred Schürmann3, Hannah Chen1, Norman Händel4, André Reis2, Gabriele Gillessen-Kaesbach3, Holm H Uhlig1,5, Rami Abou Jamra2,6.
Abstract
PTEN hamartoma tumour syndrome (PHTS) is caused by heterozygous variants in PTEN and is characterised by tumour predisposition, macrocephaly, and cognition impairment. Bi-allelic loss of PTEN activity has not been reported so far and animal models suggest that bi-allelic loss of PTEN activity is embryonically lethal. Here, we report the identification of a novel homozygous variant in PTEN, NM_000314.4; c.545T>C; p.Leu182Ser, in two adolescent siblings with severe macrocephaly and mild intellectual disability. The variant is predicted to be damaging and is associated with significantly increased phospho-S6 downstream of PTEN. The absence of tumours in the two homozygous siblings as well as lack of symptoms of PHTS in the heterozygous carriers of the family suggest that this particular variant is functionally hypomorphic rather than deleterious.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26443266 PMCID: PMC4820037 DOI: 10.1038/ejhg.2015.209
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246